These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 311720)

  • 41. Effect of chronic cocaine on behavior and cyclic AMP in cerebrospinal fluid of rhesus monkeys.
    Post RM; Smith CC; Squillace KM; Tallman JF
    Commun Psychopharmacol; 1979; 3(3):143-52. PubMed ID: 227642
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.
    Massotti M; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1974; 2(6):769-76. PubMed ID: 4549398
    [No Abstract]   [Full Text] [Related]  

  • 43. [Quantitative analysis of cerebral electrograms following administration of biogenic amines].
    Omel'chenko VP; Karkishchenko NN
    Farmakol Toksikol; 1978; 41(6):666-70. PubMed ID: 309832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 3,4-dihydro-lH-1,4-oxazino[4,3-a] indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):324-42. PubMed ID: 303083
    [No Abstract]   [Full Text] [Related]  

  • 45. Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors.
    Hutson PH; Donohoe TP; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(2):215-23. PubMed ID: 3113985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
    Herz A; Bläsig J; Papeschi R
    Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
    [No Abstract]   [Full Text] [Related]  

  • 47. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour.
    Carter CJ; Pycock CJ
    Life Sci; 1978 Sep; 23(9):953-60. PubMed ID: 568208
    [No Abstract]   [Full Text] [Related]  

  • 48. Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):337-41. PubMed ID: 7189832
    [No Abstract]   [Full Text] [Related]  

  • 49. Stimulation and inhibition of serotoninergic mechanisms in rat brain: alterations of morphine effects on striatal dopamine metabolism and on motility.
    Groppe G; Kuschinsky K
    Neuropharmacology; 1975 Sep; 14(9):659-64. PubMed ID: 1080841
    [No Abstract]   [Full Text] [Related]  

  • 50. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP; De Carolis AS; Longo VG
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract]   [Full Text] [Related]  

  • 51. Behavioral interactions in cocaine-treated rats.
    Bhattacharyya AK; Pradhan SN
    Life Sci; 1979 May; 24(20):1855-60. PubMed ID: 572461
    [No Abstract]   [Full Text] [Related]  

  • 52. The 'wet dog shake" behaviour in the rat and 5-hydroxytryptamine [proceedings].
    Bedard P; Pycock C
    Br J Pharmacol; 1977 Mar; 59(3):450P-451P. PubMed ID: 300259
    [No Abstract]   [Full Text] [Related]  

  • 53. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 54. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 55. Potentiation of the behavioral and convulsant effects of cocaine by chronic administration in the rat.
    Stripling JS; Ellinwood EH
    Pharmacol Biochem Behav; 1977 May; 6(5):571-9. PubMed ID: 561409
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of serotonin in the pathophysiology of myoclonic seizures associated with acute imipramine toxicity.
    Westheimer R; Klawans HL
    Neurology; 1974 Dec; 24(12):1175-7. PubMed ID: 4548513
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparative study of the pharmacological activity of N-(4-picolyl)-3,5-dimethylbenzamide (M-14012-4) and its N-oxide metabolite (M-3312-4). New pharmacological aspects].
    Casais L; Colom A; Martín del Río MP; Vallejo M; Cuenca E
    Arch Farmacol Toxicol; 1979 Dec; 5(3):159-64. PubMed ID: 44673
    [No Abstract]   [Full Text] [Related]  

  • 58. Protection against effects of brain damage by catecholamine depletion is test dependent.
    Lanier LP; Petit TL; Isaacson RL
    Brain Res; 1974 Dec; 82(2):374-7. PubMed ID: 4441902
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of an organophosphate (dichlorvos) on open field behavior and locomotor activity: correlation with regional brain monoamine levels.
    Ali SF; Chandra O; Hasan M
    Psychopharmacology (Berl); 1980; 68(1):37-42. PubMed ID: 6771797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of serotoninergic drugs on positive and negative reinforcing systems in cats.
    Patkina NA; Lapin IP
    Pharmacol Biochem Behav; 1976 Sep; 5(3):241-5. PubMed ID: 1087028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.